← Who reports today · Health Care
IDXX earnings date & Q2 2026 results · IDEXX Laboratories
US GAAP · $M · vs Q2 2025 · quarter ended 06/30/2026 · reported 08/04/2026
Key growth driver: Revenue growth of +10% y/y — the report gives no segment split, so the driver is the whole business. · by the Q2 2026 report
When is IDXX’s next earnings date?
Monday, November 2, 2026estimated
Expected around Nov 2 — based on last year’s report on Nov 3, 2025. We have not yet seen the company's announcement of the date.
How we estimate
The estimate is the date of the same-quarter report a year ago, per the company’s SEC filing, moved forward 52 weeks (same weekday). Companies usually keep the same week; the date will be replaced once IDXX announces it.
Same quarter a year ago (ended September 30, 2025): revenue $1.105B, EPS (GAAP) $3.40
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
What time does IDXX report? Usually before market open: the last 4 results releases reached the SEC at 6:32 am, 6:31 am, 6:39 am, 6:34 am ET.
Last report: Aug 4, 2026 (Q2 2026) — broken down in the Sankey chart below. Dates: company announcements; past dates and times — SEC 8-K filings. Who else reports this week →
All figures in $M.
Revenue
$1,217
+9.7%
Gross profit
$779
+12.1%
64.0% margin
Operating income
$426
+14.1%
35.0% margin
Net income
$338
+15.1%
$4.27/sh · 27.8% margin
Verdict: revenue grew 9.7% y/y to $1.22B, operating margin 35.0% vs 33.6%, net income $338M (+15.1% y/y).
Source and notation
Source: IDEXX Laboratories press release, 8-K EX-99.1 of 08/04/2026 (SEC EDGAR). Every figure was matched against the income statement in the release and checked against SEC XBRL.
Open the chart as a PNG image ↗ · for sharing and presentations · free to reuse, CC BY 4.0
IDXX earnings history: past report dates
| Aug 4, 2026 Tue | 6:32 ambefore market open | Jun 30, 2026 | $1.2B+10% y/y | $4.27+18% y/y |
| May 5, 2026 Tue | 6:31 ambefore market open | Mar 31, 2026 | $1.1B+14% y/y | $3.47+17% y/y |
| Feb 2, 2026 Mon | 6:39 ambefore market open | Dec 31, 2025 | ≈$1.1B+14% y/y | ≈$3.09+18% y/y |
| Nov 3, 2025 Mon | 6:34 ambefore market open | Sep 30, 2025 | $1.1B+13% y/y | $3.40+21% y/y |
| Aug 4, 2025 Mon | 6:30 ambefore market open | Jun 30, 2025 | $1.1B+11% y/y | $3.63+49% y/y |
| May 1, 2025 Thu | 6:30 ambefore market open | Mar 31, 2025 | $998M+4% y/y | $2.96+5% y/y |
| Feb 3, 2025 Mon | 6:30 ambefore market open | Dec 31, 2024 | ≈$954M+6% y/y | ≈$2.62+13% y/y |
| Oct 31, 2024 Thu | 6:30 ambefore market open | Sep 30, 2024 | $976M+7% y/y | $2.80+11% y/y |
| Aug 6, 2024 Tue | 6:30 ambefore market open | Jun 30, 2024 | $1.0B+6% y/y | $2.44−9% y/y |
| May 1, 2024 Wed | 6:30 ambefore market open | Mar 31, 2024 | $964M+7% y/y | $2.81+10% y/y |
| Feb 5, 2024 Mon | 6:30 ambefore market open | Dec 31, 2023 | ≈$902M+9% y/y | ≈$2.31+12% y/y |
| Nov 1, 2023 Wed | 6:30 ambefore market open | Sep 30, 2023 | $916M+9% y/y | $2.53+18% y/y |
| Aug 1, 2023 Tue | 6:30 ambefore market open | Jun 30, 2023 | $944M+10% y/y | $2.67+71% y/y |
| May 2, 2023 Tue | 6:34 ambefore market open | Mar 31, 2023 | $900M+8% y/y | $2.55+12% y/y |
| Feb 6, 2023 Mon | 6:31 ambefore market open | Dec 31, 2022 | ≈$829M+3% y/y | ≈$2.06+9% y/y |
| Nov 1, 2022 Tue | 6:59 ambefore market open | Sep 30, 2022 | $842M+4% y/y | $2.15+6% y/y |
Show all 16 reports since 2022Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
IDEXX Laboratories: 15-year financials
| 2025 | 4,304 | 1,360 | 1,060 | 1,057 |
| 2024 | 3,898 | 1,128 | 888 | 808 |
| 2023 | 3,661 | 1,097 | 845 | 773 |
| 2022 | 3,367 | 899 | 679 | 394 |
| 2021 | 3,215 | 932 | 745 | 636 |
| 2020 | 2,707 | 695 | 582 | 541 |
| 2019 | 2,407 | 553 | 428 | 304 |
| 2018 | 2,213 | 491 | 377 | 284 |
| 2017 | 1,969 | 413 | 263 | 299 |
| 2016 | 1,775 | 350 | 222 | 274 |
| 2015 | 1,602 | 300 | 192 | 139 |
| 2014 | 1,486 | 260 | 182 | 175 |
| 2013 | 1,377 | 267 | 188 | 168 |
| 2012 | 1,293 | 263 | 178 | 165 |
| 2011 | 1,219 | 236 | 162 | 168 |
Show all 15 yearsShow fewer
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.
Shareholders’ equity at Jun 30, 2026: $1.6B (47% of total assets). Compare with other S&P 500 companies →
Included in screener lists: S&P 500 companies with revenue growth 10 years in a row · Piotroski F-score: S&P 500 companies scoring 8 or 9
IDEXX Laboratories (IDXX) earnings: FAQ
When is IDXX's next earnings date?
We have not yet seen an announcement of the date from IDEXX Laboratories (IDXX). Based on last year's report on Nov 3, 2025, the next report is expected around Nov 2, 2026.
What time does IDXX report earnings?
IDEXX Laboratories usually reports before market open: its latest results release was filed with the SEC at 6:32 am ET on Aug 4, 2026.
When did IDXX last report earnings?
IDEXX Laboratories reported Q2 2026 results on Aug 4, 2026.
Where can I find IDEXX Laboratories's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to IDXX's filings; this page breaks the latest report down in a Sankey chart.
What was IDXX's net income in Q2 2026?
IDEXX Laboratories reported net income of $338M for Q2 2026 (+15.1% year over year), under US GAAP.
How has IDEXX Laboratories's revenue changed since 2011?
Per its 10-K filings, revenue grew 3.5x: $1,219M in 2011 and $4,304M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
How this page was made: the figures come from the company's own report on SEC EDGAR; the summary and nuances were drafted by our model from that report — two independent automated readings of the release had to match, and every number in the text was checked against it. Figures checked against the filing on 10/16/2026. How we make the breakdowns · Report an error
More reports: ILMN · Q2 2026 · INCY · Q2 2026 · IQV · Q2 2026 · ISRG · Q2 2026 · JNJ · Q3 2026 · LH · Q2 2026 · LLY · Q2 2026 · MCK · Q1 FY2027 · MDT · Q1 2027 · MRK · Q2 2026 · all reports